High contrast breast cancer biomarker imaging using upconverting nanoparticles

Sanathana Konugolu Venkata Sekar; Hui Ma; Katarzyna Komolibus; Gokhan Dumlupinar; Krzysztof Krawczyk; Matthias Mickert; Stefan Andersson-Engels

High contrast breast cancer biomarker imaging using upconverting nanoparticles

Sanathana Konugolu Venkata Sekar
, Hui Ma
, Katarzyna Komolibus
, Gokhan Dumlupinar
, Krzysztof Krawczyk
, Matthias Mickert
, Stefan Andersson-Engels

Lumito AB

Research output: Contribution to journal › Article › peer-review

Abstract

Breast cancer is a leading cause of death in women and has scope for improvement in treatment stratification. We report the use of high contrast UCNP staining to distinguish different levels of HER2 expression in HER2 analyte control and HER2-positive breast cancer tissue biopsies. A contrast of 40 was found as compared to the negative control and 25 as compared to conventional DAB staining.

Original language	English
Article number	JM1A.4
Journal	Optics InfoBase Conference Papers
Publication status	Published - 2022
Event	Clinical and Translational Biophotonics, Translational 2022 - Fort Lauderdale, United States Duration: 24 Apr 2022 → 27 Apr 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{f6504f1816ba4aa985a7ada98ce64eab,

title = "High contrast breast cancer biomarker imaging using upconverting nanoparticles",

abstract = "Breast cancer is a leading cause of death in women and has scope for improvement in treatment stratification. We report the use of high contrast UCNP staining to distinguish different levels of HER2 expression in HER2 analyte control and HER2-positive breast cancer tissue biopsies. A contrast of 40 was found as compared to the negative control and 25 as compared to conventional DAB staining.",

author = "Sekar, \{Sanathana Konugolu Venkata\} and Hui Ma and Katarzyna Komolibus and Gokhan Dumlupinar and Krzysztof Krawczyk and Matthias Mickert and Stefan Andersson-Engels",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s).; Clinical and Translational Biophotonics, Translational 2022 ; Conference date: 24-04-2022 Through 27-04-2022",

year = "2022",

language = "English",

journal = "Optics InfoBase Conference Papers",

issn = "2162-2701",

}

TY - JOUR

T1 - High contrast breast cancer biomarker imaging using upconverting nanoparticles

AU - Sekar, Sanathana Konugolu Venkata

AU - Ma, Hui

AU - Komolibus, Katarzyna

AU - Dumlupinar, Gokhan

AU - Krawczyk, Krzysztof

AU - Mickert, Matthias

AU - Andersson-Engels, Stefan

PY - 2022

Y1 - 2022

N2 - Breast cancer is a leading cause of death in women and has scope for improvement in treatment stratification. We report the use of high contrast UCNP staining to distinguish different levels of HER2 expression in HER2 analyte control and HER2-positive breast cancer tissue biopsies. A contrast of 40 was found as compared to the negative control and 25 as compared to conventional DAB staining.

AB - Breast cancer is a leading cause of death in women and has scope for improvement in treatment stratification. We report the use of high contrast UCNP staining to distinguish different levels of HER2 expression in HER2 analyte control and HER2-positive breast cancer tissue biopsies. A contrast of 40 was found as compared to the negative control and 25 as compared to conventional DAB staining.

UR - https://www.scopus.com/pages/publications/85136392066

M3 - Article

AN - SCOPUS:85136392066

SN - 2162-2701

JO - Optics InfoBase Conference Papers

JF - Optics InfoBase Conference Papers

M1 - JM1A.4

T2 - Clinical and Translational Biophotonics, Translational 2022

Y2 - 24 April 2022 through 27 April 2022

ER -

High contrast breast cancer biomarker imaging using upconverting nanoparticles

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this